Bayer Healthcare Aktiengesellschaft

Basf Aktiengesellschaft

Wolfgang Barth

Erwin Bischoff

Helmut Haning

Afssaneh Rahbar

Tiemo-Joerg Bandel

Rainer Becker

Lothar Janitschke

Maria Niewöhner

Gerald Lauterbach

Maria Theresia Niewohner, Legal Representative

Klaas Jansen

Michael Heullmann

The present invention relates to the use of known 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position and cGMP PDE-inhibitory properties for the production of medicaments for the treatment of cardiac insufficiency, psoriasis, female infertility, cancer, diabetes, ophthalmic disorders such as glaucoma, disorders of gastric motility, cystic fibrosis, premature labour, pulmonary hypertension, bladder disorders, prostate hyperplasia, nitrate-induced tolerance, pre-eclampsia, alopecia, Parkinson's disease, pain, tinnitus or the renal syndrome.

Use of 2-alkoxyphenyl-substituted imidazotriazinones

Use of 2-alkoxyphenol-substituted imidazotriazinones

Cycloalkylidene derivatives of the general formulae Ia to Ic ##STR1## where the dashed line is a possible additional chemical bond, the radicals R.sup.1 are identical or different C.sub.1 -C.sub.4 -alkenyl groups, R.sup.2 and R.sup.3 are each methyl or ethyl, R.sup.4 is hydrogen or one of the radicals R.sup.1, X is oxygen, methylene or a chemical bond, m is from 0 to 3 or, when X is methylene, is from 1 to 3, or, when X is methylene and R.sup.1 is methyl, is from 2 to 3 and n is from 0 to 3, are used as fragrance materials.

Cycloalkylidene derivatives and fragrance composition

Growing community of inventors

Wuppertal, Germany

Wolfgang Barth